Related Experiment Video
Updated: Jun 8, 2026
06:17
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Functional amyloid: turning swords into plowshares
1Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology, Aarhus University, Aarhus, Denmark. dao@inano.au.dk
Prion
|October 12, 2010
Summary
Amyloid fibers, often linked to disease, are naturally produced for beneficial purposes. Researchers discovered a new Pseudomonas operon (fap) for controlled amyloid production, distinct from E. coli
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Amyloid fibers, typically associated with neurodegenerative diseases, are increasingly recognized for their beneficial roles in nature.
- Amyloid's robust, repetitive structure makes it a durable and cost-effective biomaterial, necessitating controlled production mechanisms.
- The csg operon in E. coli and Salmonella is a well-studied example of controlled amyloid production involving specific chaperones.
Purpose of the Study:
- To investigate novel mechanisms of controlled amyloid production in bacteria.
- To characterize a newly discovered amyloid production operon (fap) in Pseudomonas.
- To compare the fap operon with the known csg operon and understand evolutionary divergence.
Main Methods:
- Bacterial genetics and molecular biology techniques.
- Bioinformatic analysis of operon structures and protein homologies.
- Biochemical characterization of amyloid components and associated proteins.
Main Results:
- Discovery of the fap operon in Pseudomonas, responsible for amyloid production and biofilm formation in E. coli.
- Identification of FapC as a key amyloid-building protein within the fap operon.
- Comparison revealed that the fap operon utilizes non-homologous chaperones with potential alternative functions, unlike the csg operon.
- FapC exhibits a less economical structure than its E. coli counterpart, with fewer repeats and larger linkers.
Conclusions:
- Controlled amyloid production has evolved independently multiple times due to the advantageous properties of amyloid materials.
- The fap operon provides a new model for studying amyloid biogenesis and regulation.
- Investigating these diverse amyloid systems offers insights into the evolution of biological materials and the management of potentially hazardous protein structures.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...